Substituted aryl sulfonamides for use as sodium channel inhibitors
MDE20260718A1Pending Publication Date: 2026-10-31XENON PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- MDE20260718T
- Authority / Receiving Office
- MD · MD
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-10-30
- Publication Date
- 2026-10-31
Abstract
The present disclosure provides compounds having Formula I: and the pharmaceutically acceptable salts, solvates, and stereoisomers thereof, wherein M1, M2, M3, M4, Z, n, R5, R6, W, A, and R9 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to inhibit sodium channels (e.g., Nav1.7) and / or to treat a disorder responsive to the inhibition of a sodium channel (e.g., Nav1.7). Compounds of the present disclosure may be useful for treating pain.
Need to check novelty before this filing date? Find Prior Art
